Abel Kakuru - Infectious Diseases

Author Information

Abel Kakuru is a researcher affiliated with the Infectious Diseases Research Collaboration in Kampala, Uganda. His work primarily focuses on various aspects of infectious diseases, with significant emphasis on malaria and its impacts, particularly during pregnancy and infancy. Abel Kakuru's research contributes to understanding the interaction between infectious agents and the human immune system, aiming to improve health outcomes through better preventive and therapeutic strategies.

Research Contributions

Abel Kakuru has made substantial contributions to the field of infectious diseases. His recent research includes studies on the impact of malaria during pregnancy, the development of optimal dosing regimens for malaria prevention in children, and the effects of in utero exposure to various factors on fetal and infant health. Notable studies include investigations into how congenital infections activate the immune system and how gestational age can be predicted using newborn metabolic screening. His work also examines the interactions between genetic traits, such as the sickle cell trait, and malaria phenotypes in infants.

Aliases

Abel Kakuru is also known by several aliases, including A Kakuru and A. Kakuru. These variations are commonly used in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Citation Count	1998
H-index	25
Paper Count	94

Publications:

Targeted newborn metabolomics: prediction of gestational age from cord blood

DOI: 10.1038/s41372-021-01253-w

Year: 2022

In Utero Activation of NK Cells in Congenital CMV Infection

DOI: 10.1101/2022.04.04.487059

Year: 2022

Exposure to pesticides in utero impacts the fetal immune system and response to vaccination in infancy

DOI: 10.1038/s41467-020-20475-8

Year: 2021

Age-Related Changes in Malaria Clinical Phenotypes During Infancy Are Modified by Sickle Cell Trait

DOI: 10.1093/cid/ciab245

Year: 2021

Impact of malaria in pregnancy and intermittent preventive treatment of malaria in pregnancy on the risk of malaria in infants

DOI: 10.17037/PUBS.04659988

Year: 2021

Gestational age dating using newborn metabolic screening: A validation study in Busia, Uganda

DOI: 10.7189/jogh.11.04012

Year: 2021

Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children

DOI: 10.1038/s41467-021-27051-8

Year: 2021

Peripheral Plasmodium falciparum infection in early pregnancy is associated with increased maternal microchimerism in the offspring.

DOI: 10.1093/infdis/jiab275

Year: 2021

The Impact of Gravidity, Symptomatology and Timing of Infection on Placental Malaria

DOI: 10.21203/rs.3.rs-23085/v1

Year: 2020

Infant sex modifies associations between placental malaria and risk of malaria in infancy

DOI: 10.1186/s12936-020-03522-z

Year: 2020

What is Efficacy?

What are the Strategies to Combat Antimicrobial Resistance?

What Are the Symptoms of Diseases Transmitted by Aedes Aegypti?

How to Choose the Right Insect Repellent?

What are the common viruses treated by DAAs?

What are Receptors?

What Are Antigen Presenting Cells?

Why is Immune System Stimulation Important?

How Do Infectious Diseases Impact Public Health?

How Does PCR Work?

Partnered Content Networks

Relevant Topics